Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
30.08    -2.74 (-8.35%)
Bid:
29.82
Ask:
30.18
Spread: 0.36 (1.207%)
Market Cap: £477.15m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Holding(s) in Company

18 Mar 2013 15:26

HAYS PLC - Holding(s) in Company

HAYS PLC - Holding(s) in Company

PR Newswire

London, March 18

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing sharesto which voting rights are attached:

Hays PLC

2. Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which mayresult in the acquisition of shares already issued to which voting rightsare attached

An acquisition or disposal of instruments with similar economic effect toqualifying financial instruments An event changing the breakdown of voting rights Other (pleasespecify): 3. Full name of person(s) subject to the notification obligation: The Capital Group Companies, Inc.4. Full name of shareholder(s)(if different from 3.): See Schedule A

5. Date of the transaction and date on which the threshold is crossed orreached:

14 March 2013

6. Date on which issuer notified: 15 March 2013 7. Threshold(s) that is/are crossed or reached: Below 6% 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous Resulting situation after the triggering transactionshares to the triggering transaction if possible Number Number Number Number of voting % of voting rightsusing of of of shares rightsthe ISIN CODE Shares Voting Rights Indirect Direct Indirect Direct Indirect Ordinary Shares 85,807,142 85,807,142 80,252,000 80,252,000 5.737%(GB0004161021) B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of votinginstrument date Conversion Period rights that may be rights acquired if the instrument is exercised/ converted. N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction Type of financial Exercise Expiration Exercise/ Number of voting rights % of voting rightsinstrument price date Conversion instrument refers to period Nominal DeltaN/A Total (A+B+C) Number of voting rights Percentage of voting rights 80,252,000 5.737%

9. Chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held, if applicable: See Schedule A Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: Due to a company reorganization,

Capital Group International, Inc.

("CGII")and Capital Research and

Management Company ("CRMC") will

no longer report relevant

holdings separate. With effect from

1 September 2012, the holdings

under management will be reported in

aggregate by the group's parent

company, The Capital Group Companies, Inc.

14. Contact name: Vivien Tan 15. Contact telephone number: 001 (213) 615-0469 Schedule A As of 14 March 2013 Hays PLC Number of shares Percent of outstanding The Capital Group Companies, Inc ("CG") holdings Holdings by CG Management Companies and Funds 80,252,000 5.737% Capital Research and Management Company 80,252,000 5.737%

Capital Income Builder

Date   Source Headline
22nd Jun 20262:15 pmRNSCorrection - Change of registered office
22nd Jun 202610:15 amRNSTransaction in Own Shares
19th Jun 20267:00 amRNSChange of registered office
17th Jun 20267:00 amRNSHays announces reshaping of country portfolio
15th Jun 202611:30 amRNSTransaction in Own Shares
10th Jun 20261:48 pmRNSDirector/PDMR Shareholding
8th Jun 202611:10 amRNSShare Buyback Programme
8th Jun 202611:05 amRNSTransaction in Own Shares
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.